MedTrace Logo

Performance Evaluation Study

NCT04618848 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2020-11-06

No results posted yet for this study

Summary

This study aims to establish OLO's performance accuracy of CBC results for finger prick samples across the OLO reportable range, and particularly around relevant medical decision points

Conditions

Interventions

DIAGNOSTIC_TEST

Fingerstick blood draw

Each participant shall be pricked twice in order to perform CBC test

Sponsors & Collaborators

  • Tel Aviv Medical Center

    collaborator OTHER

  • Sight Diagnostics

    lead INDUSTRY

Principal Investigators

  • Yochay Eshel · Sponsor GmbH

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-30
Primary Completion
2020-12-31
Completion
2020-12-31
FDA Device
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04618848 on ClinicalTrials.gov